SCHEMBL21611931

SCHEMBL21611931

Nc1cc(SCc2cnc(Br)s2)nc(C(F)(F)F)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30763502 0.77 PTGS2 (0.31) —
SCHEMBL21611947 0.76 PPARD (0.40) —
SCHEMBL21614652 0.73 CYP2C19 (0.41) —
SCHEMBL21611950 0.70 EPHX2 (0.36) —
SCHEMBL21611939 0.68 ALDH1A1 (0.43) —
SCHEMBL21611937 0.66 LOXL2 (0.38) —
SCHEMBL21611936 0.64 BACE1 (0.41) —
SCHEMBL21612006 0.64 GAA (0.44) —
SCHEMBL20583311 0.61 CDK2 (0.33) —
SCHEMBL18923095 0.58 CA2 (0.48) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11883387-B2 PqsR inverse agonists Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2024-01-30 — — US disclosed
US-20210353606-A1 PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2021-11-18 — — US disclosed
EP-3818045-A1 PQSR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2021-05-12 — — EP disclosed
WO-2020007938-A1 PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2020-01-09 — — WO disclosed
Send feedback